Lenograstim 5 µg/kg is not superior to biosimilar filgrastim 10 µg/kg in lymphoma patients undergoing peripheral blood stem cell mobilization after chemotherapy: preliminary results from a prospective randomized study.
Transfusion
; 58(5): 1143-1148, 2018 05.
Article
in En
| MEDLINE
| ID: mdl-29446445
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hematopoietic Stem Cell Mobilization
/
Filgrastim
/
Lenograstim
/
Lymphoma
Type of study:
Clinical_trials
/
Observational_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Transfusion
Year:
2018
Document type:
Article